Skip to main content
Caplight Logo









Curve

Curve

Private
MalmöHealthcare & Life Scienceshttps://curvebio.tech

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Curve operates in Healthcare & Life Sciences and is based in Malmö. It was founded in 2022.

Curve is a biotechnology company that develops modular, smart production systems for large-scale protein biomanufacturing across food, health, and cosmetic industries.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Curve Comparables

Compare Curve with similar companies based on industry and business-model similarity.

Curve comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
bbi-biotech GmbH
80%
Arsenale Bioyards
78%
Biosphere
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Curve Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Curve. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Gittan Schiöld

Co-founder Chief Commercial Officer (CCO) At Curve

Founding Team

Jacob Schaldemose Peterson

CEO Co-founder

Founding Team

Marten Schmidt

CTO

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 709% MoM, from 185 to 1.5K.

  • Nov 10, 2025

    Developing modular, intelligent production systems for food and pharma.

Book a demo to see all signals

For institutional investors. Book with your work email.

Curve Filings

Explore SEC and related filing metadata, where available.

Curve filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Curve's valuation, stock price, and market status.

Is Curve a public or private company?

Curve is a private company.

What is the current stock price of Curve?

Curve is a private company, so its shares have no public market price. Caplight tracks Curve's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Curve worth (valuation)?

Valuation information for Curve is not publicly available.

Can I buy Curve stock?

Curve shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Curve's last funding round?

Funding round information for Curve is not publicly available.

Who are the main investors in Curve?

Investor information for Curve is not publicly disclosed.

Will Curve IPO soon?

No public IPO plans have been announced for Curve.

How can I track Curve secondary market activity?

Caplight tracks bids, offers, and trades in Curve's shares on secondary markets.

Firmographic Details

HeadquartersMalmö
Employee Range9
Year Founded2022
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?